SSSPTA is essential for serine palmitoyltransferase function during development and hematopoiesis

Area of Science:

• Biochemistry
• Developmental Biology
• Hematopoiesis

Background:

• The serine palmitoyltransferase (SPT) complex catalyzes the rate-limiting step in sphingolipid biosynthesis.
• SPT complexes consist of catalytic core subunits (SPTLC1, SPTLC2/SPTLC3) and smaller subunits (SSSPTA, SSSPTB) that enhance efficiency and specificity.
• The in vivo roles of mammalian SSSPTA and SSSPTB remain largely uncharacterized.

Purpose of the Study:

• To investigate the biological significance of SSSPTA and SSSPTB in mammalian development and hematopoiesis.
• To determine the specific functions of SSSPTA within the SPT complex in vivo.

Main Methods:

• Generation and analysis of null mutants for SSSPTA (conditional) and SSSPTB.
• Embryonic lethality assessment.
• Bone marrow transplantation experiments (chimeric and competitive) in mice.
• Analysis of hematopoietic stem and progenitor cell populations.
• Assessment of endoplasmic reticulum stress markers.

Main Results:

• SSSPTA null mutants exhibit embryonic lethality at E6.5, similar to SPTLC1/SPTLC2 null mutants.
• Conditional deletion of SSSPTA leads to lethality and significant myelopoietic defects.
• SSSPTA deficiency results in stem and progenitor cell expansion and impaired myeloid differentiation, associated with ER stress.
• SSSPTB null mice are viable with no significant impact on adult hematopoietic compartment proliferation or differentiation.

Conclusions:

• SSSPTA is essential for mammalian embryogenesis and plays a critical role in hematopoietic functions.
• The SPT complex, particularly when including SSSPTA, mediates key developmental and hematopoietic processes in mammals.
• SSSPTB does not appear to be essential for adult hematopoiesis.